If you’re a member of the media working on a story about brain trauma or brain health, we can connect you with the experts at Cohen Veterans Bioscience. Please don’t hesitate to contact us.
Senior Director, Communications
Cohen Veterans Bioscience
Cohen Veterans Bioscience is a non-profit 501(c)(3) biomedical research and technology organization dedicated to advancing brain health by fast-tracking precision diagnostics and tailored therapeutics.
Follow Cohen Veterans Bioscience
Cohen Veterans Bioscience, Stanford Brain Performance Center, and Brain Trauma Foundation Join Forces to Advance Precision Medicine for TBIRead more
Cohen Veterans Bioscience, Stanford Brain Performance Center, and the Brain Trauma Foundation announced a collaboration aimed at transforming the treatment recommendations and guidelines for mild traumatic brain injury (TBI) (inclusive of concussion) and advancing the field more broadly toward a precision medicine approach.
- Read more
The new PRISM 2 project, “Psychiatric Ratings using Intermediate Stratified Markers 2,” aims to identify quantitative biological features common across Alzheimer’s disease, schizophrenia and major depressive disorder, opening the possibility of developing targeted treatments irrespective of traditional diagnosis.
Cohen Veterans Bioscience Hosts Voices of Veterans Webinar to Mark ‘Mental Health Action Day’ on May 20, 2021Read more
To commemorate the first Mental Health Action Day, brain research and advocacy nonprofit Cohen Veterans Bioscience (CVB) announces plans to host a webinar on May 20th titled “Parachuting with Purpose: A View into the Personal Experiences of Traumatic Brain Injury Among Veterans and a New Path Toward Precision Solutions.”
Traumatic Brain Injury: A New Roadmap Outlining Opportunities, Barriers, and Recommendations for Advancing Treatment SolutionsRead more
Brain research and advocacy nonprofit Cohen Veterans Bioscience (CVB) today announced the launch of a National TBI Precision Solutions Research Roadmap, with the advent of the first in a series of publications resulting from its Brain Trauma Blueprint framework program.
Cohen Veterans Bioscience And The European College Of Neuropsychopharmacology Announce The 2021 Best Negative Data Prize In Clinical NeuroscienceRead more
Cohen Veterans Bioscience and the European College of Neuropsychopharmacology (ECNP) are pleased to announce the opening of submissions for the 2021 Best Negative Data Prize in Clinical Neuroscience. The prize recognizes the researcher or research group whose publication in clinical neuroscience best exemplifies clinical data where the results do not confirm the expected outcomes or original hypotheses or results that challenge a long-standing clinical precedent.